87 related articles for article (PubMed ID: 2224769)
1. Expression of pancreatic secretory trypsin inhibitor gene in human colorectal tumor.
Tomita N; Doi S; Higashiyama M; Morimoto H; Murotani M; Kawasaki Y; Monden T; Shimano T; Horii A; Yokouchi H
Cancer; 1990 Nov; 66(10):2144-9. PubMed ID: 2224769
[TBL] [Abstract][Full Text] [Related]
2. Expression of pancreatic secretory trypsin inhibitor gene in neoplastic tissues.
Tomita N; Horii A; Yamamoto T; Ogawa M; Mori T; Matsubara K
FEBS Lett; 1987 Dec; 225(1-2):113-9. PubMed ID: 2961612
[TBL] [Abstract][Full Text] [Related]
3. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer.
Higashiyama M; Monden T; Tomita N; Murotani M; Kawasaki Y; Morimoto H; Murata A; Shimano T; Ogawa M; Mori T
Br J Cancer; 1990 Dec; 62(6):954-8. PubMed ID: 2257226
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA.
Yamamoto T; Nakamura Y; Nishide J; Emi M; Ogawa M; Mori T; Matsubara K
Biochem Biophys Res Commun; 1985 Oct; 132(2):605-12. PubMed ID: 3877508
[TBL] [Abstract][Full Text] [Related]
5. Human trypsinogen in colorectal cancer.
Williams SJ; Gotley DC; Antalis TM
Int J Cancer; 2001 Jul; 93(1):67-73. PubMed ID: 11391623
[TBL] [Abstract][Full Text] [Related]
6. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.
Solakidi S; Tiniakos DG; Petraki K; Stathopoulos GP; Markaki I; Androulakis G; Sekeris CE
Histol Histopathol; 2003 Oct; 18(4):1181-8. PubMed ID: 12973686
[TBL] [Abstract][Full Text] [Related]
8. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
9. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
11. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
[TBL] [Abstract][Full Text] [Related]
12. Impaired expression of acyl-CoA synthetase 5 in sporadic colorectal adenocarcinomas.
Gassler N; Herr I; Schneider A; Penzel R; Langbein L; Schirmacher P; Kopitz J
J Pathol; 2005 Nov; 207(3):295-300. PubMed ID: 16110457
[TBL] [Abstract][Full Text] [Related]
13. Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors.
Batra SK; Hollingsworth MA
Int J Pancreatol; 1991; 10(3-4):287-92. PubMed ID: 1787340
[TBL] [Abstract][Full Text] [Related]
14. On the cDNA's for two types of rat pancreatic secretory trypsin inhibitor.
Horii A; Tomita N; Yokouchi H; Doi S; Uda K; Ogawa M; Mori T; Matsubara K
Biochem Biophys Res Commun; 1989 Jul; 162(1):151-9. PubMed ID: 2751646
[TBL] [Abstract][Full Text] [Related]
15. A tumor-suppressive role for trypsin in human cancer progression.
Yamashita K; Mimori K; Inoue H; Mori M; Sidransky D
Cancer Res; 2003 Oct; 63(20):6575-8. PubMed ID: 14583448
[TBL] [Abstract][Full Text] [Related]
16. The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
Hirota M; Ohmuraya M; Baba H
J Gastroenterol; 2006 Sep; 41(9):832-6. PubMed ID: 17048046
[TBL] [Abstract][Full Text] [Related]
17. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer.
Koskensalo S; Hagström J; Louhimo J; Stenman UH; Haglund C
Oncology; 2012; 82(4):234-41. PubMed ID: 22508321
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
[TBL] [Abstract][Full Text] [Related]
19. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas.
Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH
J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-1 in human colorectal carcinoma.
Shiozawa J; Ito M; Nakayama T; Nakashima M; Kohno S; Sekine I
Mod Pathol; 2000 Sep; 13(9):925-33. PubMed ID: 11007031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
